[go: up one dir, main page]

DK0622077T3 - Angiotensin-II-antagonister som profylaktisk eller terapeutisk middel til nyresygdomme - Google Patents

Angiotensin-II-antagonister som profylaktisk eller terapeutisk middel til nyresygdomme

Info

Publication number
DK0622077T3
DK0622077T3 DK94106203T DK94106203T DK0622077T3 DK 0622077 T3 DK0622077 T3 DK 0622077T3 DK 94106203 T DK94106203 T DK 94106203T DK 94106203 T DK94106203 T DK 94106203T DK 0622077 T3 DK0622077 T3 DK 0622077T3
Authority
DK
Denmark
Prior art keywords
stands
prophylactic
angiotensin
antagonists
therapeutic agent
Prior art date
Application number
DK94106203T
Other languages
Danish (da)
English (en)
Inventor
Kohei Nishikawa
Keiji Kubo
Yumiko Shibouta
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of DK0622077T3 publication Critical patent/DK0622077T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4245—Oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK94106203T 1993-04-22 1994-04-21 Angiotensin-II-antagonister som profylaktisk eller terapeutisk middel til nyresygdomme DK0622077T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9594293 1993-04-22

Publications (1)

Publication Number Publication Date
DK0622077T3 true DK0622077T3 (da) 2000-10-23

Family

ID=14151326

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94106203T DK0622077T3 (da) 1993-04-22 1994-04-21 Angiotensin-II-antagonister som profylaktisk eller terapeutisk middel til nyresygdomme

Country Status (12)

Country Link
US (7) US5719173A (ja)
EP (1) EP0622077B1 (ja)
JP (1) JP3810020B2 (ja)
AT (1) ATE194284T1 (ja)
BR (1) BR1100756KB1 (ja)
CA (1) CA2121871C (ja)
CY (1) CY2204B1 (ja)
DE (1) DE69425085T2 (ja)
DK (1) DK0622077T3 (ja)
ES (1) ES2149226T3 (ja)
GR (1) GR3033862T3 (ja)
PT (1) PT622077E (ja)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003306432A (ja) * 1993-04-22 2003-10-28 Takeda Chem Ind Ltd 腎疾患の予防または治療剤
JP3810020B2 (ja) 1993-04-22 2006-08-16 武田薬品工業株式会社 腎疾患の予防または治療剤
US5721263A (en) * 1993-06-07 1998-02-24 Takeda Chemical Industries, Ltd. Pharmaceutical composition for angiotensin II-mediated diseases
WO1996024512A1 (fr) * 1995-02-10 1996-08-15 Enshu Co., Ltd. Boucle de suspension de ceinture de securite
CA2228251A1 (en) * 1996-06-11 1997-12-18 Zonagen, Inc. Chitosan drug delivery system
AU5576498A (en) * 1997-02-05 1998-08-26 Sankyo Company Limited Prophylactic or therapeutic agent for diabetic complication
US8273866B2 (en) * 2002-02-20 2012-09-25 Merck Sharp & Dohme Corp. RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (SINA)
PL356422A1 (en) 2000-02-18 2004-06-28 Takeda Chemical Industries, Ltd. Tnf-alpha inhibitors
US7087608B2 (en) 2000-03-03 2006-08-08 Robert Charles Atkins Use of PDGF receptor tyrosine kinase inhibitors for the treatment of diabetic nephropathy
WO2004071534A1 (ja) * 2003-02-17 2004-08-26 Takeda Pharmaceutical Company Limited 腎疾患の予防・治療剤
US7021099B2 (en) * 2003-06-12 2006-04-04 General Motors Corporation Extraction system for hot formed parts
CA2547785A1 (en) * 2003-12-19 2005-07-21 Merck & Co., Inc. Cyclic guanidines, compositions containing such compounds and methods of use
KR20070074576A (ko) * 2004-10-29 2007-07-12 코와 가부시키가이샤 사구체 질환 치료제
TW200719896A (en) * 2005-04-18 2007-06-01 Astrazeneca Ab Combination product
AR057455A1 (es) 2005-07-22 2007-12-05 Merck & Co Inc Inhibidores de la transcriptasa reversa de vih y composicion farmaceutica
EA016593B1 (ru) * 2007-03-28 2012-06-29 Такеда Фармасьютикал Компани Лимитед ТВЕРДАЯ ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ВКЛЮЧАЮЩАЯ ПРОИЗВОДНОЕ БЕНЗИМИДАЗОЛ-7-КАРБОКСИЛАТА И pH РЕГУЛИРУЮЩИЙ АГЕНТ
CN102196809B (zh) * 2008-10-22 2013-06-26 协和发酵麒麟株式会社 糖尿病性肾病的治疗剂
ES2712086T3 (es) 2010-06-17 2019-05-09 Nitto Denko Corp Agente para tratar la fibrosis renal

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5128256A (en) * 1987-01-12 1992-07-07 Stratagene DNA cloning vectors with in vivo excisable plasmids
DE3928177A1 (de) * 1989-04-08 1991-02-28 Thomae Gmbh Dr K Benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
CA2016710A1 (en) * 1989-05-15 1990-11-15 Prasun K. Chakravarty Substituted benzimidazoles as angiotensin ii antagonists
DE69013607T2 (de) * 1989-08-02 1995-03-02 Takeda Chemical Industries Ltd Pyrazol-Derivate, Verfahren zu deren Herstellung und Anwendung.
DE3927170A1 (de) * 1989-08-17 1991-02-21 Boehringer Ingelheim Kg Inhalator
US5250554A (en) * 1989-10-24 1993-10-05 Takeda Chemical Industries, Ltd. Benzimidazole derivatives useful as angiotensin II inhibitors
IL95975A (en) * 1989-10-24 1997-06-10 Takeda Chemical Industries Ltd N-benzyl- 2-alkylbenzimidazole derivatives, their production and pharmaceutical compositions containing them
EP0430300A3 (en) * 1989-12-01 1992-03-25 Takeda Chemical Industries, Ltd. Xanthine derivatives, their production and use
EP0434038A1 (en) * 1989-12-22 1991-06-26 Takeda Chemical Industries, Ltd. Fused imidazole derivatives, their production and use
CA2036304C (en) * 1990-02-15 2001-04-17 Takehiko Naka Pyrimidinedione derivatives, their production and use
US5284661A (en) * 1990-02-22 1994-02-08 Takeda Chemical Industries, Ltd. Fused thiophene derivatives, their production and use
CA2037630C (en) * 1990-03-07 2001-07-03 Akira Morimoto Nitrogen-containing heterocylic compounds, their production and use
US5196444A (en) * 1990-04-27 1993-03-23 Takeda Chemical Industries, Ltd. 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof
DK0461039T3 (da) * 1990-06-08 1999-06-14 Hoechst Marion Roussel Inc Nye benzimidazolafledte forbindelser, fremgangsmåde til deres fremstilling, de opnåede mellemprodukter, deres anvendelse so
WO1992000067A2 (en) * 1990-06-22 1992-01-09 E.I. Du Pont De Nemours And Company Treatment of chronic renal failure with imidazole angiotensin-ii receptor antagonists
AU8405691A (en) * 1990-09-04 1992-03-30 Yamanouchi Pharmaceutical Co., Ltd. Novel tetrahydrobenzazole derivative
AU636066B2 (en) * 1990-10-30 1993-04-08 Takeda Chemical Industries Ltd. Thienoimidazole derivatives, their production and use
GB9027210D0 (en) * 1990-12-14 1991-02-06 Smithkline Beecham Plc Medicaments
TW274551B (ja) * 1991-04-16 1996-04-21 Takeda Pharm Industry Co Ltd
IL102183A (en) * 1991-06-27 1999-11-30 Takeda Chemical Industries Ltd The heterocyclic compounds are converted into biphenyl groups, their production and the pharmaceutical compositions containing them
US5500427A (en) * 1992-09-14 1996-03-19 Takeda Chemical Industries, Ltd. Cyclic compounds and their use
EP0603712B1 (en) * 1992-12-22 2001-08-16 Takeda Chemical Industries, Ltd. Heterocyclic compounds having angiotensin II antagonistic activity and use thereof
JP3810020B2 (ja) 1993-04-22 2006-08-16 武田薬品工業株式会社 腎疾患の予防または治療剤

Also Published As

Publication number Publication date
US6319938B1 (en) 2001-11-20
GR3033862T3 (en) 2000-10-31
US6469037B2 (en) 2002-10-22
EP0622077A1 (en) 1994-11-02
CY2204B1 (en) 2002-11-08
CA2121871C (en) 2006-12-12
US20020045652A1 (en) 2002-04-18
US5719173A (en) 1998-02-17
DE69425085T2 (de) 2000-11-09
JPH072667A (ja) 1995-01-06
BR1100756KB1 (pt) 2011-10-18
US20030114509A1 (en) 2003-06-19
US7135490B2 (en) 2006-11-14
ATE194284T1 (de) 2000-07-15
JP3810020B2 (ja) 2006-08-16
CA2121871A1 (en) 1994-10-23
PT622077E (pt) 2000-10-31
US5889036A (en) 1999-03-30
US20040082636A1 (en) 2004-04-29
DE69425085D1 (de) 2000-08-10
US6686383B2 (en) 2004-02-03
EP0622077B1 (en) 2000-07-05
ES2149226T3 (es) 2000-11-01
US6040324A (en) 2000-03-21

Similar Documents

Publication Publication Date Title
DK0622077T3 (da) Angiotensin-II-antagonister som profylaktisk eller terapeutisk middel til nyresygdomme
DE69725978D1 (de) Chalcon-derivate und medikamente die diese enthalten
SE0302760D0 (sv) New compounds
ECSP045104A (es) Ligandos de los receptores de los cannabinoides
DE69432644D1 (de) Kombination eines Angiotensin-II antagonistisch wirkendes Benzimidazols mit ein Diuretikum
NO955256D0 (no) Fenylheterosykluser som syklooksygenase-2-inhibitorer
DE60237528D1 (de) Neue aminoazetidin-, aminopyrrolidin- und aminopiperidinderivative
ATE433971T1 (de) Neue azolderivate
ATE337318T1 (de) Spiroverbindungen und diese als wirkstoff enthaltende adhäsionsmolekülinhibitoren
DK1233953T3 (da) Nye benzoethiadiazinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende samme
EP1329218A4 (en) PREVENTIVE / REMEDY AGENTS FOR PORTAL HYPERTENSION
SE0303480D0 (sv) Benzofuranes
ATE274515T1 (de) Pyrazolopyridinderivate
NO20002321L (no) Bifenylderivater som farmasøytiske midler
ATE519755T1 (de) Modulatoren des vitamin-d-rezeptors
ATE374751T1 (de) 3,4-dihydro-1h-chinolin-2-onderivate als norepinephrin-wiederaufnahme-hemmern
PT1065209E (pt) Novos inibidores de metaloproteases, processo para a sua preparacao e as composicoes farmaceuticas que os comtem
DE60132920D1 (de) Biphenylderivate
TH38253A (th) อนุพันธ์ 6,6-เฮเทอโร-ไบไซคลิคที่ถูกเข้าแทนที่
TH41374A (th) สารประกอบทางเภสัชกรรมประเภทใหม่
ECSP992966A (es) Compuestos de amindazol
TH66556A (th) สารยับยั้งเมททัลโลโพรทีเนส สไพโร-ไพริมิดีน-2,4,6-ไตรโอน